- Home
- LRMR vs RAC Comparison
LRMR vs RAC Comparison
Compare LRMR & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.41
Company Overview
Basic Information| Metric | LRMR | RAC |
|---|---|---|
| Founded | N/A | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.1M | 304.4M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | LRMR | RAC |
|---|---|---|
| Price | $3.41 | $10.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.71 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 35.6K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $9.87 |
| 52 Week High | $5.37 | $10.45 |
Technical Indicators
Market Signals| Indicator | LRMR | RAC |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | N/A |
| Support Level | $3.12 | N/A |
| Resistance Level | $4.15 | N/A |
| Average True Range (ATR) | 0.27 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 37.38 | 0.00 |
Price Performance
Historical Comparison LRMR
RAC
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About RAC Rithm Acquisition Corp. Class A Ordinary Shares
Rithm Acquisition Corp is a blank check company.